How We Review Medical Content

Every article on this site about a prescription medicine is drafted by a qualified writer and checked by a medical reviewer before it publishes. The review checks the drug facts, any dose we mention, the safety information and the regulatory status against primary sources — principally the manufacturer’s prescribing information. Both people are named below, with their credentials and their own profile pages, so you can see who they are rather than take our word for it.

That last part is the point of this page. “Medically reviewed” is a marketing phrase until you can see who did the reviewing, what they are qualified in, and what they actually checked. Below is all three.

Who Writes and Who Reviews

Dr. Kimberly Hines, PharmD — Medical Content Writer

Kimberly holds a Doctor of Pharmacy and has spent more than eight years writing healthcare content. Her focus on this site is erectile dysfunction, men’s sexual wellness and online pharmacy education — sildenafil, tadalafil and the rest of that catalogue.

She writes; she does not sign off her own work. A PharmD is a doctorate in pharmacy rather than a medical degree, so the clinical check stays a separate job done by a separate person. Keeping those two roles apart is the whole reason the second name on this page exists.

Dr. Priyanka Mehta, MD (Pharmacology), MBBS — Medical Reviewer

Dr. Mehta holds an MBBS and an MD in Pharmacology — the branch of medicine concerned with how medicines act in the body, how they interact with one another, and how they are dosed safely. That is a directly relevant specialism for a catalogue of prescription medicines rather than a general one.

She checks the medicine information published here before it goes live: that the active ingredient, strength and dosage form shown on a page match the manufacturer’s prescribing information, that the conditions a medicine is described as treating are stated accurately, and that safety information, warnings and interactions are present and correctly worded.

Her review covers the catalogue as a whole — erectile dysfunction and men’s health, diabetes, cardiovascular and respiratory medicines, antivirals, oncology and eye care.

What the Review Actually Checks

A review is a line-by-line check against primary sources, not a read-through. Specifically:

1. Drug facts. Active ingredient, strength, dosage form, drug class and manufacturer, checked against the prescribing information.
2. Dosage statements. Every dose mentioned is checked against approved labelling. Where a product is sold at a strength above the approved maximum, the page has to say so explicitly — several products in this catalogue are, and the articles about them name it in the opening paragraph.
3. Safety content. Side effects, contraindications and interactions are checked for accuracy and for completeness — specifically that serious effects have not been left out, buried or softened.
4. Regulatory status. Whether a product is FDA-approved is stated accurately, and approval of an active ingredient is never presented as approval of a brand. These are different things and conflating them is the most common error in this category.
5. Claims. No cure, no guarantee, and no efficacy claim beyond what the evidence supports. Anything evidence-based carries a citation.
6. Sources. Citations point to primary or authoritative sources, and the links resolve. A dead citation is treated as no citation.
7. Emergency information. Where it is relevant — priapism, chest pain, sudden vision or hearing loss — the page tells you when to stop reading and call 911.

One boundary worth stating: a medical review is an accuracy check on published text. It is not medical advice and it is not a consultation. Dr. Mehta is checking an article; she is not treating you, and reading something she checked does not create a clinical relationship.

The Sources We Use

Our sources are limited to manufacturer prescribing information and recognised references. In practice that means the FDA-approved labelling — read directly, usually through DailyMed, the National Library of Medicine’s label database — plus MedlinePlus for patient-facing drug information, PubMed and the NIH for research, and clinical guidance from bodies such as the American Urological Association.

What we do not cite is more informative than what we do. We do not cite other online pharmacies. We do not cite supplement retailers. We do not cite content farms, and we do not cite any source that is selling the product being described. That rule costs us citations on exactly the terms where they would be easiest to find, which is rather the point of having it.

Outbound links to authoritative sources open in a new tab. We would rather you went and read the label.

How Often We Re-check

Our re-review is triggered by events rather than by a calendar: pages are re-checked when the underlying prescribing information changes.

We state it that way because it is what we actually do. A fixed interval published on a page like this is a promise that every article’s visible date will eventually either confirm or contradict, and an annual promise that is met is worth more than a six-monthly one that is missed. A label change, an FDA safety communication, significant new research, or a reader telling us we have got something wrong will each prompt a re-check outside any cycle.

Every article shows the date it was published and the date it was last updated. Where a correction is material — a wrong dose, a missing contraindication, a claim we could not support — we would rather note it on the article than quietly edit it and move on.

What Our Content Is Not

Our articles are general information. They are not a diagnosis, not a prescription, and not advice about your particular situation. Nobody here has examined you.

Our side-effect and interaction lists are not complete, and we say so on every article that carries one. The prescribing information is complete. Your pharmacist is better than any article, including ours, because they can see your other medicines.

Dose selection is a medical decision and we do not make recommendations about it. This deserves more than a sentence, because of what we sell: a number of the products in our catalogue are manufactured at strengths above the FDA-approved maximum single dose. Sildenafil is approved in the United States at 25, 50 and 100 mg, with 100 mg the maximum single dose — and products exist at 120, 150 and 200 mg. Tadalafil is approved up to 20 mg, and products exist at 40, 60 and 80 mg. Where we write about those strengths, the article states that they sit above the approved range, and it does not tell you to take them.

We sell the products we write about. That is a commercial interest and it belongs on this page rather than in small print, because you would find out anyway and you should hear it from us. Our answer to it is the separation of roles above: the person who checks an article is not the person who wrote it, and neither of them is paid on what it sells.

Report an Error

If you think something on this site is wrong, tell us through our contact page. Reports go to the editorial lead, and anything clinical goes to Dr. Mehta. If we got it wrong we fix it.

That route is for content errors. It cannot give you medical advice and we will not try. Questions about your own treatment belong with your prescriber or pharmacist. If this is an emergency — chest pain, an erection lasting more than four hours, sudden loss of vision or hearing — call 911 rather than emailing us.